156 related articles for article (PubMed ID: 35292679)
1. A genetic risk score of alleles related to MGUS interacts with socioeconomic position in a population-based cohort.
Baak L; Frank M; Dürig J; Dührsen U; Hoffmann P; Nöthen MM; Dragano N; Erbel R; Jöckel KH; Schmidt B
Sci Rep; 2022 Mar; 12(1):4409. PubMed ID: 35292679
[TBL] [Abstract][Full Text] [Related]
2. Socioeconomic Position is Positively Associated with Monoclonal Gammopathy of Undetermined Significance in a Population-based Cohort Study.
Schmidt B; Debold E; Frank M; Arendt M; Dragano N; Dürig J; Dührsen U; Moebus S; Erbel R; Jöckel KH; Eisele L
Ann Hematol; 2019 Dec; 98(12):2761-2767. PubMed ID: 31691002
[TBL] [Abstract][Full Text] [Related]
3. Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance.
Clay-Gilmour AI; Hildebrandt MAT; Brown EE; Hofmann JN; Spinelli JJ; Giles GG; Cozen W; Bhatti P; Wu X; Waller RG; Belachew AA; Robinson DP; Norman AD; Sinnwell JP; Berndt SI; Rajkumar SV; Kumar SK; Chanock SJ; Machiela MJ; Milne RL; Slager SL; Camp NJ; Ziv E; Vachon CM
Blood Adv; 2020 Jun; 4(12):2789-2797. PubMed ID: 32569378
[TBL] [Abstract][Full Text] [Related]
4. Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics.
Greenberg AJ; Rajkumar SV; Vachon CM
Blood; 2012 Jun; 119(23):5359-66. PubMed ID: 22354002
[TBL] [Abstract][Full Text] [Related]
5. Inherited genetic susceptibility to monoclonal gammopathy of unknown significance.
Weinhold N; Johnson DC; Rawstron AC; Försti A; Doughty C; Vijayakrishnan J; Broderick P; Dahir NB; Begum DB; Hosking FJ; Yong K; Walker BA; Hoffmann P; Mühleisen TW; Langer C; Dörner E; Jöckel KH; Eisele L; Nöthen MM; Hose D; Davies FE; Goldschmidt H; Morgan GJ; Hemminki K; Houlston RS
Blood; 2014 Apr; 123(16):2513-7; quiz 2593. PubMed ID: 24449210
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal Gammopathy of Undetermined Significance: Current Concepts and Future Prospects.
Seth S; Zanwar S; Vu L; Kapoor P
Curr Hematol Malig Rep; 2020 Apr; 15(2):45-55. PubMed ID: 32222885
[TBL] [Abstract][Full Text] [Related]
7. Enrichment of B cell receptor signaling and epidermal growth factor receptor pathways in monoclonal gammopathy of undetermined significance: a genome-wide genetic interaction study.
Chattopadhyay S; Thomsen H; da Silva Filho MI; Weinhold N; Hoffmann P; Nöthen MM; Marina A; Jöckel KH; Schmidt B; Pechlivanis S; Langer C; Goldschmidt H; Hemminki K; Försti A
Mol Med; 2018 Jun; 24(1):30. PubMed ID: 30134812
[TBL] [Abstract][Full Text] [Related]
8. Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study.
Chang SH; Luo S; O'Brian KK; Thomas TS; Colditz GA; Carlsson NP; Carson KR
Lancet Haematol; 2015 Jan; 2(1):e30-6. PubMed ID: 26034780
[TBL] [Abstract][Full Text] [Related]
9. Genomewide association study on monoclonal gammopathy of unknown significance (MGUS).
Thomsen H; Campo C; Weinhold N; da Silva Filho MI; Pour L; Gregora E; Vodicka P; Vodickova L; Hoffmann P; Nöthen MM; Jöckel KH; Langer C; Hajek R; Goldschmidt H; Hemminki K; Försti A
Eur J Haematol; 2017 Jul; 99(1):70-79. PubMed ID: 28375557
[TBL] [Abstract][Full Text] [Related]
10. Prior autoimmune disease and risk of monoclonal gammopathy of undetermined significance and multiple myeloma: a systematic review.
McShane CM; Murray LJ; Landgren O; O'Rorke MA; Korde N; Kunzmann AT; Ismail MR; Anderson LA
Cancer Epidemiol Biomarkers Prev; 2014 Feb; 23(2):332-42. PubMed ID: 24451437
[TBL] [Abstract][Full Text] [Related]
11. A genetic sum score of risk alleles associated with body mass index interacts with socioeconomic position in the Heinz Nixdorf Recall Study.
Frank M; Dragano N; Arendt M; Forstner AJ; Nöthen MM; Moebus S; Erbel R; Jöckel KH; Schmidt B
PLoS One; 2019; 14(8):e0221252. PubMed ID: 31442235
[TBL] [Abstract][Full Text] [Related]
12. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Björkholm M; Landgren O; Kristinsson SY
JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
[TBL] [Abstract][Full Text] [Related]
14. Interaction of Alzheimer's Disease-Associated Genetic Risk with Indicators of Socioeconomic Position on Mild Cognitive Impairment in the Heinz Nixdorf Recall Study.
Frank M; Hensel J; Baak L; Schramm S; Dragano N; Weimar C; Hoffmann P; Nöthen MM; Erbel R; Jöckel KH; Jokisch M; Schmidt B
J Alzheimers Dis; 2021; 82(4):1715-1725. PubMed ID: 34219719
[TBL] [Abstract][Full Text] [Related]
15. Multiple Myeloma and Its Precursor Disease Among Firefighters Exposed to the World Trade Center Disaster.
Landgren O; Zeig-Owens R; Giricz O; Goldfarb D; Murata K; Thoren K; Ramanathan L; Hultcrantz M; Dogan A; Nwankwo G; Steidl U; Pradhan K; Hall CB; Cohen HW; Jaber N; Schwartz T; Crowley L; Crane M; Irby S; Webber MP; Verma A; Prezant DJ
JAMA Oncol; 2018 Jun; 4(6):821-827. PubMed ID: 29710195
[TBL] [Abstract][Full Text] [Related]
16. Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis.
Go RS; Gundrum JD; Neuner JM
Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):177-186.e4. PubMed ID: 25445471
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study.
Rognvaldsson S; Eythorsson E; Thorsteinsdottir S; Vidarsson B; Onundarson PT; Agnarsson BA; Sigurdardottir M; Thorsteinsdóttir I; Olafsson I; Runolfsdottir HL; Helgason D; Emilsdottir AR; Agustsson AS; Bjornsson AH; Kristjansdottir G; Thordardottir AR; Indridason OS; Jonsson A; Gislason GK; Olafsson A; Steingrimsdottir H; Kampanis P; Hultcrantz M; Durie BGM; Harding S; Landgren O; Palsson R; Love TJ; Kristinsson SY
Blood Cancer J; 2021 Dec; 11(12):191. PubMed ID: 34853309
[TBL] [Abstract][Full Text] [Related]
18. Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study.
Grass S; Preuss KD; Ahlgrimm M; Fadle N; Regitz E; Pfoehler C; Murawski N; Pfreundschuh M
Lancet Oncol; 2009 Oct; 10(10):950-6. PubMed ID: 19767238
[TBL] [Abstract][Full Text] [Related]
19. Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma.
Greenberg AJ; Rajkumar SV; Larson DR; Dispenzieri A; Therneau TM; Colby CL; Phelps TK; Kumar SK; Katzmann JA; Kyle RA; Slager SL; Vachon CM
Br J Haematol; 2012 May; 157(4):472-5. PubMed ID: 22629552
[TBL] [Abstract][Full Text] [Related]
20. Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort Study.
Landgren O; Shim YK; Michalek J; Costello R; Burton D; Ketchum N; Calvo KR; Caporaso N; Raveche E; Middleton D; Marti G; Vogt RF
JAMA Oncol; 2015 Nov; 1(8):1061-8. PubMed ID: 26335650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
